The XIX International AIDS Conference (AIDS 2012) that took place last week in Washington, D.C., “ignited momentum to shift from ‘fighting AIDS’ to ‘ending AIDS,'” Mohga Kamal-Yanni, senior health adviser at Oxfam International, and Urvarshi Rajcoomer, policy and advocacy adviser at Oxfam in South Africa, write in a Mail & Guardian opinion piece. “Oxfam believes investing in health systems such as infrastructure and health worker, drug supply chain and health information systems, is a critical prerequisite to ending AIDS,” they write. However, “to make this a reality,” pharmaceutical companies, donor governments, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the World Bank “must now do their part,” they continue.
In this post on the Center for Global Development’s (CGD) “Global Health Policy” blog, CGD’s Victoria Fan, Rachel Silverman, and Amanda Glassman examine “the preliminary report [.pdf] on the pilot of PEPFAR’s Expenditure Analysis Initiative, an important and exciting move by PEPFAR towards evidence-based decision making and greater transparency.” Expenditure analysis (EA) “provides an account of where money gets spent and on what,” they continue, adding, “Here’s why it could be a game changer: This seemingly simple tool is essential for realizing huge potential gains in both technical and allocative efficiency, two core components of value for money.” After describing some of the report’s shortcomings, they write that “the report demonstrates the wide range of potential applications for using EA to improve value for money, which is particularly encouraging given PEPFAR’s plans to institutionalize EA into its routine annual reporting” (8/1).
Noting the United Nations last week “announced the appointment of Dr. Michel Kazatchkine, the former head of the Global Fund to Fight AIDS, Tuberculosis and Malaria, as the U.N. Secretary-General’s new special envoy for HIV/AIDS in Eastern Europe and Central Asia,” Kasia Malinowska-Sempruch, director of the Open Society Foundations’ global drug policy program, writes in this Huffington Post opinion piece, “[W]hile Dr. Kazatchkine’s skills will be principally devoted to a handful of E.U. Member States and some neighbors, all of Europe would be wise to heed his guidance on the importance of sensible drug policies in the HIV response.” She continues, “As a member of the Global Commission on Drug Policy — a body of experts from politics, health, academia and business — Dr. Kazatchkine reminded leaders that ‘the war on drugs has fueled the HIV epidemic.'”
“Former President Bill Clinton delivered an energizing ‘call to action’ at the closing session of [the XIX International AIDS Conference (AIDS 2012)], encapsulating the high hopes and the sobering challenges facing the fight against global HIV/AIDS,” Janet Fleischman, a senior associate at the Center for Strategic & International Studies’ (CSIS) Global Health Policy Center, writes in the center’s “Smart Global Health” blog. “In order to build the necessary political momentum going forward, he focused on certain key areas: supporting greater commitments from affected countries, driving down the costs of treatment, and creating innovative financing mechanisms to accompany traditional donor funding,” she notes, and highlights key messages from his Closing Session address (7/31). A webcast of the session is available online from the Kaiser Family Foundation.
“Health care, taxes, energy, favorite flavor of ice cream — it seems our elected leaders must disagree at every turn. But one issue that has so far repulsed the partisan pressures of the times was highlighted [at the XIX International AIDS Conference (AIDS 2012)] in our nation’s capital last week: the fight against HIV/AIDS,” former Senate Majority Leader Bill Frist (R-Tenn.) writes in an opinion piece in “The Week.” He says, “The conference was a celebration of the remarkable success made because of this leadership, and a call for continued support” in the response against HIV/AIDS. Noting he moderated a panel discussion with Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on congressional bipartisanship at the conference, Frist continues, “I witnessed what I felt to be an accurate portrayal of how we got to the point where we could celebrate so many successes. Fundamental to the progress has been bipartisanship.”
Highlighting a recently released UNAIDS and Kaiser Family Foundation report (.pdf) on the financing of the global response to HIV/AIDS in low- and middle-income countries in 2011, Devex assesses the HIV/AIDS initiatives and funding levels of the five leading donor governments for that year. According to the report, the United States, the United Kingdom, France, the Netherlands, and Germany “collectively contributed $6.5 billion, or nearly 86 percent, of all international HIV/AIDS assistance” in 2011, Devex notes before detailing these contributions by country (Piccio, 7/30).
Namibian High Court Rules HIV-Positive Women Were Improperly Counseled Before Sterilization Procedures, But Not Based On HIV Status
“The Namibian High Court has ruled that the human rights of three HIV-positive women were violated when they were coerced into being sterilized while they gave birth, but the judge dismissed claims that the sterilization amounted to discrimination based on their HIV status,” PlusNews reports (7/30). “The court ruled the three were sterilized without being adequately informed,” Reuters notes. “There should be unhurried counseling in a language that is clearly understood by the patient,” Windhoek High Court Judge Elton Hoff said, adding, “I am not convinced that informed consent was given,” the news service reports (7/30).
In her “Global Health Blog,” Guardian health editor Sarah Boseley notes that she spoke with USAID Administrator Rajiv Shah during last week’s XIX International AIDS Conference (AIDS 2012). She writes that though he “has a very clear vision of where USAID is going and what it hopes to achieve … [h]e appears to be a little concerned, however, that Europe may not keep pace — particularly on the finance but perhaps also on the approach.” She continues to say “Shah’s main anxiety is clearly … about the diminishing funding from European allies for the efforts to turn the tide of AIDS … but also about the financial commitment to global health generally.”
“The International AIDS Conference [AIDS 2012] was full of talk of hope and best practices, but no one was giving details on how to reach an ‘AIDS-free generation,'” GlobalPost correspondent John Donnelly writes in this post in the “Global Pulse” blog. “Still, this conference, like many before it, had several key moments when it was clear that the world of AIDS had changed,” he adds, and highlights a summit of faith groups organized by Rick and Kay Warren of Saddleback Church and held on the sidelines of the conference. “Saddleback’s work in Africa follows what it calls the PEACE Plan, which stands for planting churches that promote reconciliation; equipping servant leaders; assisting the poor; caring for the sick; and educating the next generation,” he notes.
Lawrence Altman, former senior medical correspondent for the New York Times, writes in an opinion analysis in the newspaper that while there was much discussion about “ending the AIDS epidemic” and an “AIDS-free generation” at the XIX International AIDS Conference (AIDS 2012) last week in Washington, D.C., “[o]ne obstacle is a failure to clearly define the epidemic or what it means to have an AIDS-free generation.” He continues, “Definitions of terms like these may help determine how many billions of dollars the world devotes to the battle against AIDS and how many millions of lives will be extended. A failure to meet ill-defined goals could lead to public misunderstandings that limit investments and the number of people who have access to the lifesaving antiretroviral drugs in the future.”